Primecap Management Co. CA bought a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 35,700 shares of the company’s stock, valued at approximately $4,587,000.
Several other large investors also recently added to or reduced their stakes in the stock. Frazier Financial Advisors LLC purchased a new stake in Merck KGaA during the 2nd quarter valued at $25,000. Rakuten Securities Inc. bought a new stake in Merck KGaA during the 2nd quarter valued at about $27,000. Solstein Capital LLC bought a new stake in shares of Merck KGaA during the second quarter valued at approximately $33,000. Burk Holdings LLC bought a new position in Merck KGaA in the second quarter worth approximately $39,000. Finally, Bard Associates Inc. bought a new position in Merck KGaA in the second quarter worth approximately $60,000. 0.10% of the stock is owned by institutional investors.
Merck KGaA Trading Up 0.4%
MKGAF opened at $164.58 on Thursday. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The stock’s fifty day moving average is $163.19 and its two-hundred day moving average is $148.83. The company has a market capitalization of $21.27 billion, a P/E ratio of 25.13 and a beta of 0.96. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
